What causes gynecomastia (enlargement of breast tissue) in a male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Gynecomastia in men is primarily caused by an imbalance between estrogen and testosterone hormones, leading to enlarged breast tissue, and can result from various factors including hormonal changes, certain medications, health conditions, and substance use. This condition can be triggered by hormonal changes during puberty, aging, obesity, and certain medications such as spironolactone, ketoconazole, cimetidine, finasteride, certain antipsychotics, and some HIV medications 1. Health conditions like liver disease, kidney failure, hyperthyroidism, and certain tumors can also contribute to gynecomastia, as well as substance use, particularly anabolic steroids, marijuana, alcohol, and heroin 1.

The underlying mechanism involves increased estrogen activity or decreased testosterone effect, disrupting the normal hormone balance. Excess fat tissue in obesity converts testosterone to estrogen, while aging naturally decreases testosterone levels 1. In many cases, especially during puberty, gynecomastia resolves on its own, but persistent cases may require addressing the underlying cause or medical intervention. According to the American College of Radiology, gynecomastia is the most common cause of a palpable mass, breast enlargement, or pain in men, and is often bilateral, presenting as a soft, rubbery, or firm mobile mass directly under the nipple 1.

Key factors that contribute to gynecomastia include:

  • Hormonal changes during puberty, aging, and obesity
  • Certain medications, such as spironolactone, ketoconazole, and finasteride
  • Health conditions, including liver disease, kidney failure, and hyperthyroidism
  • Substance use, particularly anabolic steroids and marijuana
  • Excess fat tissue in obesity, which converts testosterone to estrogen
  • Aging, which naturally decreases testosterone levels 1.

It is essential to identify the underlying cause of gynecomastia to provide appropriate treatment and prevent potential complications. If the differentiation between benign disease and breast cancer cannot be made on the basis of clinical findings, or if the clinical presentation is suspicious, imaging is indicated, with ultrasound recommended for men younger than 25 and mammography or digital breast tomosynthesis for men 25 and older 1.

From the FDA Drug Label

Spironolactone can cause gynecomastia. In a Randomized Spironolactone Evaluation Study, patients with heart failure treated with a mean dose of 26 mg of spironolactone once daily, about 9% of the male subjects developed gynecomastia. The risk of gynecomastia increases in a dose-dependent manner with an onset that varies widely from 1 to 2 months to over a year. Gynecomastia is usually reversible. Gynecomastia has been reported in patients treated for one month or longer. In patients being treated for pathological hypersecretory states, this occurred in about 4% of cases while in all others the incidence was 0. 3% to 1% in various studies.

Gynecomastia in men can be caused by certain medications, including:

  • Spironolactone 2: The risk of gynecomastia increases in a dose-dependent manner.
  • Cimetidine 3: Gynecomastia has been reported in patients treated for one month or longer, with an incidence of about 4% in patients with pathological hypersecretory states and 0.3% to 1% in other cases.

From the Research

Causes of Gynecomastia

  • Gynecomastia is a benign proliferation of glandular tissue of the breast in men, caused by an imbalance between estrogen and androgen action at the level of breast tissue 4, 5, 6, 7
  • It can be caused by various factors, including:
    • Physiological conditions, such as neonatal period, puberty, and senescence 5, 7
    • Hormonal imbalances, such as estrogen excess and/or androgen deficiency 4, 6, 7
    • Certain medications, which can cause hypogonadism, anti-androgenic effects, and hyperprolactinemia 8
    • Underlying medical conditions, such as liver failure and chronic kidney disease 7
    • Idiopathic causes, where the underlying cause is unknown 6

Risk Factors

  • Age: Gynecomastia is common in adolescents and adults, and its prevalence increases with age 4, 5
  • Medications: Certain medications, such as exogenous estrogens, anti-androgens, and certain antibiotics, can increase the risk of gynecomastia 8
  • Hormonal imbalances: Conditions that affect hormone levels, such as hypogonadism and hyperthyroidism, can increase the risk of gynecomastia 4, 6, 7
  • Family history: A family history of gynecomastia may increase the risk of developing the condition 4

Diagnosis and Treatment

  • Diagnosis of gynecomastia involves a thorough medical history, physical examination, and laboratory tests to rule out underlying medical conditions and identify the underlying cause 4, 5, 6
  • Treatment options for gynecomastia include:
    • Watchful waiting: For mild cases of gynecomastia, where the condition may resolve on its own 4
    • Medical therapy: For cases of gynecomastia caused by hormonal imbalances or certain medications, medical therapy may be effective 4, 8, 6
    • Surgery: For chronic and severe cases of gynecomastia, surgical removal of the breast tissue may be necessary 4, 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gynecomastia: incidence, causes and treatment.

Expert review of endocrinology & metabolism, 2011

Research

Gynecomastia and hormones.

Endocrine, 2017

Research

Drug-induced gynecomastia.

Expert opinion on drug safety, 2008

Related Questions

What causes gynecomastia (enlargement of breast tissue in males)?
Is gynecomastia typically idiopathic or multifactorial?
What are the causes of gynecomastia (enlargement of breast tissue in males)?
What is the etiology of gynecomastia?
What other physical exams should be performed when evaluating a patient for gynecomastia?
What is the management of a 47-year-old patient with chronic left upper quadrant (LUQ) pain, sludge on computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) showing mid common bile duct (CBD) dilation and distal CBD stricture, with normal liver function tests (LFTs), and a possible choledochocele, who underwent endoscopic retrograde cholangiopancreatography (ERCP) with dilation of the CBD stricture and removal of sludge/debris, resulting in pain resolution?
What are the causes of hip pain in an athletic adult?
What is the management of a 47-year-old patient with chronic left upper quadrant (LUQ) pain, sludge on computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) showing mid common bile duct (CBD) dilation and distal CBD stricture, with normal liver function tests (LFTs), and a possible choledochocele, who underwent endoscopic retrograde cholangiopancreatography (ERCP) with dilation of the CBD stricture and removal of sludge/debris, resulting in pain resolution?
How to manage hypokalemia (low potassium level) of 3.1 mEq/L?
How to manage hypokalemia (low potassium) of 3.1 mEq/L?
What is the management of a 47-year-old patient with chronic left upper quadrant (LUQ) pain, sludge on computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) showing mid common bile duct (CBD) dilation and distal CBD stricture, normal liver function tests (LFTs), and an anomalous pancreaticobiliary junction, who underwent endoscopic retrograde cholangiopancreatography (ERCP) with dilation of the CBD stricture and removal of sludge/debris, and was also considered for a choledochocele?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.